MedTrace Logo

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

NCT01981109 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2019-08-28

Study results available
· View outcomes & findings →

Summary

The primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant prostate cancer and no known distant metastases.

Conditions

  • Castration-Resistant Prostate Cancer

Sponsors & Collaborators

  • Dendreon

    lead INDUSTRY

Principal Investigators

  • Bruce Brown, MD · Dendreon Pharmaceuticals, LLC

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01981109 on ClinicalTrials.gov